AU Patent

AU2013217013B2 — Modified release formulations of viloxazine

Assigned to Supernus Pharmaceuticals Inc · Expires 2017-04-20 · 9y expired

What this patent protects

Modified release formulations of viloxazine and methods of administering the same are disclosed. High- drug load formulations of viloxazine are further disclosed.

USPTO Abstract

Modified release formulations of viloxazine and methods of administering the same are disclosed. High- drug load formulations of viloxazine are further disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013217013B2
Jurisdiction
AU
Classification
—
Expires
2017-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Supernus Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.